Condition
LSIL, Low-Grade Squamous Intraepithelial Lesions
Total Trials
4
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Unknown2
Completed1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07029152Not ApplicableRecruiting
Screening for Anal Cancer in Men Who Have Sex With Men Using Pre-Exposure Prophylaxis
NCT05051852Unknown
HPV Viral Load in Predicting the Prognosis of LSIL
NCT05283239Unknown
Research About Impact of HPV Integration on the Prognosis of Women With Persistent HR-HPV Infection
NCT02331550Not ApplicableCompletedPrimary
Observational vs. Ablative Treatment for Low-grade Squamous Intraepithelial Lesions.
Showing all 4 trials